Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer

Affiliations

¹ Service Biostatistique et épidémiologie.
² Département D'oncologie et de Radiothérapie, Gustave Roussy, Villejuif, France.
³ Service Biostatistique et épidémiologie. Electronic address: jean-pierre.pignon@gustaveroussy.fr.

Free article

Comment

B Lueza et al. Ann Oncol. 2014 Sep.

Free article

. 2014 Sep;25(9):1865-1866.

doi: 10.1093/annonc/mdu221. Epub 2014 Jun 11.

¹ Service Biostatistique et épidémiologie.
² Département D'oncologie et de Radiothérapie, Gustave Roussy, Villejuif, France.
³ Service Biostatistique et épidémiologie. Electronic address: jean-pierre.pignon@gustaveroussy.fr.

No abstract available

Comment in

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.
Parmar MK, Torri V, Stewart L. Parmar MK, et al. Stat Med. 1998 Dec 30;17(24):2815-34. doi: 10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8. Stat Med. 1998. PMID: 9921604 Clinical Trial.
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.
Sun JM, Ahn YC, Choi EK, Ahn MJ, Ahn JS, Lee SH, Lee DH, Pyo H, Song SY, Jung SH, Jo JS, Jo J, Sohn HJ, Suh C, Lee JS, Kim SW, Park K. Sun JM, et al. Ann Oncol. 2013 Aug;24(8):2088-92. doi: 10.1093/annonc/mdt140. Epub 2013 Apr 16. Ann Oncol. 2013. PMID: 23592701 Clinical Trial.